The association between dietary selenium intake and diabetes: a cross-sectional study among middle-aged and older adults
© Wei et al.; licensee BioMed Central. 2015
Received: 30 October 2014
Accepted: 9 February 2015
Published: 18 February 2015
Selenium is an important trace element for human health. Although numerous epidemiological and interventional studies have examined the association between selenium and diabetes, their findings have been inconclusive. Moreover, no research has specifically focused on the association between dietary selenium and diabetes in the Asian population. The objective of this study was to evaluate the relationship between dietary selenium and diabetes in middle-aged and elderly Chinese adults.
A cross-sectional study including 5,423 subjects was carried out. The basic characteristics, biochemical test results, and dietary intake were collected from each subject for analysis. The adjusted odds ratio (OR) and the corresponding 95% confidence interval (CI) were used to determine the relationship between dietary selenium intake and diabetes through logistic regression.
The prevalence of diabetes in the study population was 9.7%, and the average level of dietary selenium intake was 43.51 μg/day. The multivariate adjusted OR was 1.52 (95% CI: 1.01 to 2.28, P = 0.04) for the highest quartile of dietary selenium intake in comparison with the lowest quartile. There was a significant positive association between dietary selenium intake and diabetes (P for trend = 0.03).
There was a significant positive correlation between dietary selenium intake and the prevalence of diabetes.
KeywordsDietary selenium Diabetes Cross-sectional study
Selenium, which plays a crucial role in human health, is a basic component of selenoprotein, an important enzyme in the body. As suggested by several previous studies, selenoproteins play a functional role in redox homeostasis, thyroid hormone metabolism, and protection from oxidative stress and inflammation . Most selenium-enriched foods are natural foods such as organ meat, seafood, cereals, and crops. The level of selenium intake varies greatly among individuals and populations . For example, it is commonly low in Europe but high in Venezuela, Canada, the United States, and Japan [1,3]. According to a previous study , in China the level of selenium intake exhibited huge variance among different population groups.
In view of its important function in protection against oxidative stress, selenium was suggested to play a protective role against type 2 diabetes . However, the association between selenium and diabetes is in fact very complicated. Although numerous epidemiological studies have explored this association, their findings have been inconclusive. Some researchers concluded that a high level of selenium could reduce the prevalence of diabetes [6-8], whereas others suggested that a high level of serum selenium could be related to the increased prevalence of diabetes [9,10]. Meanwhile, the results of the Selenium and Vitamin E Cancer Trial (SELECT) rejected any significant relationship between supplementary selenium and the risk of type 2 diabetes . However, the outcomes of a post hoc analysis of the Nutritional Prevention of Cancer (NPC) trial revealed a significantly increased risk for type 2 diabetes in participants taking supplementary selenium .
Previous studies have suggested that the specific association between selenium and diabetes remains unclear. Researchers often focused on the association between diabetes and the selenium concentration in serum, plasma, or nail. Of the limited number of studies thus far to assess the association between dietary selenium and diabetes, one concluded that an increase in dietary selenium intake was associated with an increased risk of type 2 diabetes . It is noteworthy that there was an absence of data focusing on the association between dietary selenium and diabetes in the Asian population. Moreover, the level of dietary selenium intake varied greatly among different population groups because of differences in geographical location and dietary habits.
In view of the current research status, the objective of this study was to assess the average level of dietary selenium intake in the central south area of China, and to examine the association between dietary selenium and diabetes in a large sample from the Chinese population by means of a cross-sectional study.
With the support and promotion of the Chinese government, routine health checkups have become very common in China. In this study, registered nurses interviewed all participants during a medical examination using a standard questionnaire, with the purpose of collecting information on demographic characteristics and health-related habits. The protocol of this study had been approved by the Ethics Committees on Research of the Xiangya Hospital, Central South University (No. 201312459). Subjects were screened according to the following inclusion criteria: (1) aged 40 years or older; (2) undergoing a blood glucose test; (3) availability of all basic characteristics, including age, gender, waist circumference, and body mass index (BMI); and (4) completion of the Semi-Quantitative Food Frequency Questionnaire (SFFQ) about food and drink consumption over the past year and the structured questionnaire containing demographic information and lifestyle habits (smoking, alcohol consumption, and regular exercise). A total of 10,370 subjects aged 40 years or older underwent a blood glucose test during the study period, 10,355 of whom made their basic characteristics available. Ultimately 5,423 subjects completed the SFFQ and the structured questionnaire. The response rate of the SFFQ was 52.4%.
Dietary intake was evaluated using a version of the SFFQ specially designed for the Chinese population. This SFFQ contains 63 food items that are popularly and commonly consumed in Hunan province. The participants were requested to answer how frequently (never, once a month, 2–3 times a month, 1–3 times a week, 4–5 times a week, once a day, twice a day, or more than twice a day) they consumed each food item, and the average amount in grams of consumption (<100, 100–200, 201–300, 301–400, 401–500, and >500) each time they ate during the past year. Color pictures of food samples with labeled weight were provided to help the participants make choices more easily and accurately. The validity of the SFFQ was estimated by comparing the results with the 24-h dietary recall method for the same population. The SFFQ was validated in a subsample of 55 subjects randomly chosen from the study population. The correlation between the SFFQ and the 24-h recalls on the measurement of selenium intake was 0.30. The Chinese Food Composition Table  was used to calculate the individual composition of macronutrients and micronutrients of the included food items.
Blood glucose assessment
All blood samples were drawn after a 12-h overnight fast and were kept at 4°C until analysis. Blood fasting glucose was measured using the glucose oxidase enzyme method. Diabetes was defined as a fasting blood glucose concentration ≥7.0 mmol/L or currently undergoing drug treatment for control of blood glucose.
Quantitative data were expressed as mean ± standard deviation, and qualitative data as a percentage. The selenium intake was classified into four categories based on the quartile distribution in the study population: ≤29.56, 29.57–40.14, 40.15–52.20, and ≥52.21 μg/day. Differences in the continuous data were evaluated by one-way analysis of variance (normally distributed data) or the Kruskal–Wallis H test (non-normally distributed data). Differences in the qualitative data were assessed by the χ2 test. The odds ratio (OR) with 95% confidence interval (CI) for the association between selenium intake and diabetes were calculated for each quartile of selenium intake, and the lowest quartile was regarded as the reference category. To calculate the adjusted OR for each quartile of selenium intake, a multivariables model was adopted to perform multivariate logistic analyses. The multivariables model included age, sex, BMI (calculated as weight in kg divided by height in m2), activity level, waist circumference, hypertension, alcohol consumption, smoking status, energy intake, fiber intake, and nutritional supplementation status. Tests for linear trends were conducted using logistic regression with a median variable of selenium level in each category. Subgroup analyses were conducted to investigate the potential interaction between selenium intake and sex or BMI. Multivariable adjusted ORs and related 95% CIs were calculated in the sex subgroup (male and female) and the BMI subgroup (BMI ≥25 or BMI <25). All data analyses were performed using SPSS 17.0. P < 0.05 was considered to be statistically significant.
Characteristics of the study population according to dietary selenium intake
Median Se intake (μg/day)
53.54 ± 7.76
53.40 ± 7.47
52.89 ± 7.57
52.38 ± 7.27
Sex (% female)
Education level (% with or above high school background)
Employment (% manual worker)
24.03 ± 3.28
24.33 ± 3.15
24.50 ± 3.16
24.99 ± 3.06
Activity level (h/week)
2.25 ± 3.82
2.19 ± 3.42
2.21 ± 3.35
2.42 ± 3.53
Waist circumference (cm)
81.51 ± 9.10
82.58 ± 8.80
83.10 ± 8.83
84.63 ± 8.68
Nutritional supplementation (%)
Energy intake (Kcal/day)
1036.84 ± 9.63
1392.87 ± 321.78
1703.74 ± 388.07
2419.71 ± 1010.46
Fiber intake (g/day)
9.63 ± 6.86
15.00 ± 8.78
19.40 ± 10.68
29.00 ± 18.73
5.66 ± 1.52
5.62 ± 1.45
5.75 ± 1.70
5.84 ± 1.83
Characteristics of the study population according to diabetic status
54.70 ± 7.33
52.87 ± 7.53
Sex (% female)
Education level (% with or above high school background)
Employment (% manual worker)
25.68 ± 3.06
24.33 ± 3.17
Activity level (h/week)
2.39 ± 3.65
2.25 ± 3.52
Waist circumference (cm)
86.85 ± 8.15
82.54 ± 8.91
Nutritional supplementation (%)
Energy intake (Kcal/day)
1752.53 ± 915.48
1625.60 ± 764.22
Fiber intake (g/day)
19.79 ± 17.77
18.08 ± 13.59
Se intake (μg/day)
46.76 ± 25.29
43.16 ± 22.35
Multivariable-adjusted relationship between dietary selenium intake and diabetes in total population, sex subgroup and BMI subgroup
Quartiles of Se intake
P for trend
Median Se intake (μg/day)
*Multivariable adjusted OR
1.10 (0.82, 1.48)
1.32 (0.94, 1.86)
1.52 (1.01, 2.28)
1.12 (0.74, 1.69)
1.31 (0.84, 2.05)
1.51 (0.90, 2.52)
1.13 (0.73, 1.75)
1.38 (0.79, 2.41)
1.39 (0.68, 2.86)
BMI ≥ 25
1.21 (0.77, 1.89)
1.52 (0.91, 2.54)
1.99 (1.09, 3.63)
BMI < 25
1.00 (0.67, 1.49)
1.16 (0.73, 1.84)
1.20 (0.69, 2.10)
We conducted a cross-sectional study on a large sample comprising 5,423 middle-aged and older adults in Hunan province, China, the primary objective being to investigate the association between dietary selenium and diabetes. The prevalence of diabetes in the study population was 9.7%, which was very close to the estimated level based on a representative sample of Chinese adults in 2010 (11.6%) . The results indicated that there was a significant positive association between dietary selenium intake and the prevalence of diabetes.
Although several studies have reported an association between selenium intake (dietary or supplementary) and diabetes, their conclusions are inconsistent. Only one study explored the relationship between dietary selenium intake and risk of type 2 diabetes in northern Italy , and concluded that increased dietary selenium intake was associated with an increased risk of type 2 diabetes. Meanwhile, some studies focused on the effect of supplementary selenium on diabetes. For example, a randomized, placebo-controlled trial suggested that selenium supplementation may be associated with adverse effects on blood glucose homeostasis in patients with type 2 diabetes , while another also observed a significantly increased risk for type 2 diabetes in a population taking a selenium supplement . Nevertheless, the results of the Selenium and Vitamin E Cancer Trial (SELECT) rejected any significant relationship between supplementary selenium and the risk of type 2 diabetes . In addition, a number of epidemiological and interventional studies also reached contradictory conclusions on the relationships between diabetes and serum selenium, plasma selenium, and nail selenium [6-10,12,18-23]. Findings from the Third National Health and Nutrition Examination Survey (NHANES III)  and NHANES 2003–2004  both demonstrated a positive association between serum selenium and the prevalence of diabetes. This was confirmed by a previous meta-analysis  suggesting a small increased risk of type 2 diabetes with selenium supplementation, although this did not reach statistical significance (pooled relative risk 1.06, 95% CI 0.97–1.15).
The findings of the present study suggested a significant positive association between dietary selenium intake and diabetes, consistent with the conclusions of studies on associations between dietary selenium and diabetes , supplementary selenium and diabetes , and serum selenium and diabetes [9,10]. Selenium has multiple and complex effects on the human body. In view of its antioxidant capacity, selenium is expected to exhibit an antidiabetic effect. Therefore, some researchers have suggested a protective role for selenium intake, as it could resist oxidative stress-related chronic complications in the progression of diabetes [25-27]. However, the therapeutic range of selenium is relatively narrow, and some selenium compounds could generate toxic reactive oxygen species . Overaccumulation of reactive oxygen species may increase insulin resistance and impair pancreatic β-cell function [28-31]. An increased level of dietary selenium intake may increase the release of glucagon, which can lead to hyperglycemia . In addition, a high level of dietary selenium intake may result in excess expression of glutathione peroxidase 1 (GPx1), which is a type of antioxidant selenoprotein. The high activity of GPx1 can interfere with insulin signaling, which is critical to the regulation of glucose levels and the prevention of diabetes . A review article  that comprehensively investigated the association between selenium and type 2 diabetes concluded that this complicated relationship may be explained by the possible harm that occurs both below and above the physiological range for optimal activity of some or all selenoproteins. The present study and a previous one  were both conducted on a population with mean dietary selenium intake close to the RNI, but the association in a population with very low dietary selenium intake may be different. Previous review articles suggested that the association between selenium and diabetes might be U-shaped: selenoproteins both below and above the physiological range might become a risk factor for diabetes [1,3,34].
The major strength of this report lies in it being the first to evaluate the association between dietary selenium intake and diabetes in an Asian population. Most previous studies of this relationship have been conducted in the United States or Europe. It is worthwhile demonstrating this association particularly for the Asian population because differences in ethnicity, geographical locations, and dietary habits can potentially affect the results. More importantly, this study is the second to explore the relationship between dietary selenium intake and diabetes using a large-sample, cross-sectional design, and its findings are consistent with those of the former . However, there are also several limitations to this research. First, this cross-sectional study is unable to explain the causal relationship, so further prospective studies are needed to confirm our conclusion. Second, owing to constraint of resources, serum or plasma selenium was not measured for the target population in this study. Study of the relationships between dietary selenium, serum selenium, and diabetes may provide a more comprehensive understanding of this topic. Another potential limitation may lie in the selection bias of the study population. The participants who were undergoing a health examination in the hospital may not represent the general population. However, the large sample size of this study enabled us to examine the association between dietary selenium intake and diabetes using multivariable logistic regression modeling with comprehensive adjustments of confounders. The prevalence of diabetes in the target population was 9.7%, which was very close to the level estimated on the basis of a representative sample of Chinese adults in 2010 , therefore suggesting reasonable representativeness of the study population.
The average level of dietary selenium intake is 43.51 μg/day among middle-aged and older Chinese adults in Hunan province, China. There is a significant positive correlation between dietary selenium intake and the prevalence of diabetes in the target population.
Written informed consent was obtained from the patient for the publication of this report and any accompanying images.
We are very grateful to all participants included in the present study, and the Health Management Center of Xiangya Hospital for their kind assistance in collecting the data and samples.
This work was supported by the Fundamental Research Funds for the Central Universities from Central South University (2014zzts070), Hunan Provincial Innovation Foundation for Postgraduate from Education Department of Hunan province (CX2014B096).
- Rayman MP. Selenium and human health. Lancet. 2012;379:1256–68.View ArticlePubMedGoogle Scholar
- Rayman MP. Food-chain selenium and human health: emphasis on intake. Br J Nutr. 2008;100:254–68.PubMedGoogle Scholar
- Rayman MP, Stranges S. Epidemiology of selenium and type 2 diabetes: can we make sense of it? Free Radic Biol Med. 2013;65:1557–64.View ArticlePubMedGoogle Scholar
- Yu SY, Mao BL, Xiao P, Yu WP, Wang YL, Huang CZ, et al. Intervention trial with selenium for the prevention of lung cancer among tin miners in Yunnan, China. A pilot study. Biol Trace Elem Res. 1990;24:105–8.View ArticlePubMedGoogle Scholar
- Steinbrenner H, Sies H. Protection against reactive oxygen species by selenoproteins. Biochim Biophys Acta. 2009;1790:1478–85.View ArticlePubMedGoogle Scholar
- Navarro-Alarcon M, Lopez-G DLSH, Perez-Valero V, Lopez-Martinez C. Serum and urine selenium concentrations as indicators of body status in patients with diabetes mellitus. Sci Total Environ. 1999;228:79–85.View ArticlePubMedGoogle Scholar
- Kljai K, Runje R. Selenium and glycogen levels in diabetic patients. Biol Trace Elem Res. 2001;83:223–9.View ArticlePubMedGoogle Scholar
- Rajpathak S, Rimm E, Morris JS, Hu F. Toenail selenium and cardiovascular disease in men with diabetes. J Am Coll Nutr. 2005;24:250–6.View ArticlePubMedGoogle Scholar
- Bleys J, Navas-Acien A, Guallar E. Serum selenium and diabetes in U.S. adults. Diabetes Care. 2007;30:829–34.View ArticlePubMedGoogle Scholar
- Laclaustra M, Navas-Acien A, Stranges S, Ordovas JM, Guallar E. Serum selenium concentrations and diabetes in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2003–2004. Environ Health Perspect. 2009;117:1409–13.View ArticlePubMedPubMed CentralGoogle Scholar
- Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009;301:39–51.View ArticlePubMedGoogle Scholar
- Stranges S, Marshall JR, Natarajan R, Donahue RP, Trevisan M, Combs GF, et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med. 2007;147:217–23.View ArticlePubMedGoogle Scholar
- Stranges S, Sieri S, Vinceti M, Grioni S, Guallar E, Laclaustra M, et al. A prospective study of dietary selenium intake and risk of type 2 diabetes. BMC Public Health. 2010;10:564.View ArticlePubMedPubMed CentralGoogle Scholar
- Yang Y. Chinese Food Composition Table. Beijing, China:Peking University Medical Press; 2009.Google Scholar
- Sun C. Nutrition and Food Hygiene. Beijing, China: People's Medical Publishing House; 2013.Google Scholar
- Xu Y, Wang L, He J, Bi Y, Li M, Wang T, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310:948–59.View ArticlePubMedGoogle Scholar
- Faghihi T, Radfar M, Barmal M, Amini P, Qorbani M, Abdollahi M, Larijani B. A Randomized, Placebo-Controlled Trial of Selenium Supplementation in Patients With Type 2 Diabetes: Effects on Glucose Homeostasis, Oxidative Stress, and Lipid Profile. Am J Ther. 2014;21:491-5.Google Scholar
- Czernichow S, Couthouis A, Bertrais S, Vergnaud AC, Dauchet L, Galan P, et al. Antioxidant supplementation does not affect fasting plasma glucose in the Supplementation with Antioxidant Vitamins and Minerals (SU.VI.MAX) study in France: association with dietary intake and plasma concentrations. Am J Clin Nutr. 2006;84:395–9.PubMedGoogle Scholar
- Gao S, Jin Y, Hall KS, Liang C, Unverzagt FW, Ji R, et al. Selenium level and cognitive function in rural elderly Chinese. Am J Epidemiol. 2007;165:955–65.View ArticlePubMedPubMed CentralGoogle Scholar
- Coudray C, Roussel AM, Mainard F, Arnaud J, Favier A. Lipid peroxidation level and antioxidant micronutrient status in a pre-aging population; correlation with chronic disease prevalence in a French epidemiological study (Nantes, France). J Am Coll Nutr. 1997;16:584–91.PubMedGoogle Scholar
- Hughes K, Aw TC, Kuperan P, Choo M. Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore. J Epidemiol Community Health. 1997;51:394–9.View ArticlePubMedPubMed CentralGoogle Scholar
- Akbaraly TN, Arnaud J, Rayman MP, Hininger-Favier I, Roussel AM, Berr C, et al. Plasma selenium and risk of dysglycemia in an elderly French population: results from the prospective Epidemiology of Vascular Ageing Study. Nutr Metab (Lond). 2010;7:21.View ArticleGoogle Scholar
- Gao H, Hagg S, Sjogren P, Lambert PC, Ingelsson E, van Dam RM. Serum selenium in relation to measures of glucose metabolism and incidence of Type 2 diabetes in an older Swedish population. Diabet Med. 2014;31:787–93.View ArticlePubMedGoogle Scholar
- Rees K, Hartley L, Day C, Flowers N, Clarke A, Stranges S. Selenium supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;1, CD009671.PubMedGoogle Scholar
- Mueller AS, Mueller K, Wolf NM, Pallauf J. Selenium and diabetes: an enigma? Free Radic Res. 2009;43:1029–59.View ArticlePubMedGoogle Scholar
- Steinbrenner H, Speckmann B, Pinto A, Sies H. High selenium intake and increased diabetes risk: experimental evidence for interplay between selenium and carbohydrate metabolism. J Clin Biochem Nutr. 2011;48:40–5.View ArticlePubMedGoogle Scholar
- Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev. 2001;17:189–212.View ArticlePubMedGoogle Scholar
- Evans JL, Maddux BA, Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal. 2005;7:1040–52.View ArticlePubMedGoogle Scholar
- Fridlyand LE, Philipson LH. Oxidative reactive species in cell injury: Mechanisms in diabetes mellitus and therapeutic approaches. Ann N Y Acad Sci. 2005;1066:136–51.View ArticlePubMedGoogle Scholar
- Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006;440:944–8.View ArticlePubMedGoogle Scholar
- Oberley LW. Free radicals and diabetes. Free Radic Biol Med. 1988;5:113–24.View ArticlePubMedGoogle Scholar
- Satyanarayana S, Sekhar JR, Kumar KE, Shannika LB, Rajanna B, Rajanna S. Influence of selenium (antioxidant) on gliclazide induced hypoglycaemia/anti hyperglycaemia in normal/alloxan-induced diabetic rats. Mol Cell Biochem. 2006;283:123–7.View ArticlePubMedGoogle Scholar
- Goldstein BJ, Mahadev K, Wu X. Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets. Diabetes. 2005;54:311–21.View ArticlePubMedPubMed CentralGoogle Scholar
- Rocourt CR, Cheng WH. Selenium supranutrition: are the potential benefits of chemoprevention outweighed by the promotion of diabetes and insulin resistance? Nutrients. 2013;5:1349–65.View ArticlePubMedPubMed CentralGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.